Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Lung Neoplasms 3Prostatic Neoplasms 2Pituitary Neoplasms 2Colorectal Neoplasms 2Breast Neoplasms 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Supratentorial Neoplasms 1Recurrence 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Ovarian Cysts 1Neoplastic Cells, Circulating 1Neoplasms 1Neoplasm Metastasis 1Myofibroma 1Melanoma 1Liver Functions Tests 1Hepatic Tumor Resection 1Gallbladder Neoplasms 1Colonic Neoplasms 1Cholecystitis 1Cholangiocarcinoma 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1Brain Edema 1Adenocarcinoma 1

Interventions

Sorafenib 131lenvatinib 115Bevacizumab 88Radiosurgery 69atezolizumab 55sintilimab 54Nivolumab 51durvalumab 43Hepatectomy 43Fluorouracil 42apatinib 41Oxaliplatin 41camrelizumab 38Radiofrequency Ablation 38pembrolizumab 36Radiotherapy 36tislelizumab 35Leucovorin 31Magnetic Resonance Spectroscopy 30Immune Checkpoint Inhibitors 28Doxorubicin 28Folfox protocol 26tremelimumab 25regorafenib 25Cisplatin 20spartalizumab 19donafenib 19Gemcitabine 19Cyclophosphamide 19toripalimab 18

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Carcinoma, Hepatocellular × Desflurane × Clear all
NCT02174575 2023-05-03

Anesthetic Agents and Acute Kidney Injury After Liver Resection Surgery

Tokyo Medical and Dental University

Phase 4 Withdrawn
Gastrointestinal

Gallbladder Neoplasms, Carcinoma, Hepatocellular, Cholangiocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡